Green stocks: 1 to buy and 1 to avoid

G A Chester discusses a green energy stock and a specialist asset manager. But which would he buy and which would he avoid?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There was a time when investing in green stocks was largely a niche activity. Many mainstream investors believed such stocks were likely to deliver sub-optimal returns.

However, with changing political and consumer priorities, the orthodoxy has shifted. Many investors now see companies with a green agenda as likely big winners of the future. Green has gone mainstream.

Here, I’ll discuss a specialist asset manager and a green energy stock. The valuation of one is too rich for me. But I think the premium price of the other is worth paying.

Impressive growth

Founded in 1998, Impax Asset Management (LSE: IPX) has been a pioneer in the development of investing in the transition to a more sustainable global economy. Its funds have become increasingly popular.

For the six months to 31 March, Impax reported record net inflows of £6.8bn. This, and impressive market gains of £3bn, lifted its assets under management (AUM) from £20.2bn at the start of the period to £30bn at the end. It also reported that after the period end, AUM had increased further to £32.2bn by 30 April.

Valuation

My rule of thumb for asset managers is to buy when the stock is valued at below 3% of AUM. I’d hold at up to 4%. And then sell (if I owned the stock) or avoid (if I didn’t) should it get above 4%. Impax is currently valued at 4.7% of AUM. As such, I’m avoiding it at the present time.

It’s possible I could miss out by sticking to my rule of thumb. Impax is increasing AUM at an impressive rate and could perhaps rapidly ‘grow into’ its valuation. In a recent research note, Equity Development has projected AUM to reach £72bn by 2025. However, I’m not swayed by FOMO (fear of missing out) or a current-year forecast dividend yield of 1.1%.

A green stock I’d buy

Right now, I’m much keener on investing in wind farms owner Greencoat UK Wind (LSE: UKW). The company has established a strong track record of acquiring high-quality assets since coming to market in 2013. And in its annual results, issued in February, it said: “The pipeline of potential acquisitions remains healthy.”

The UK government’s plan for a Green Industrial Revolution to achieve carbon neutrality by 2050 requires a quadrupling of current offshore wind generation capacity. And Greencoat’s increasing scale gives it the ability to invest in offshore wind farms (typically significantly larger than onshore).

Valuation

Greencoat is scheduled to announce its half-year results and latest net asset value (NAV) on 28 July. Based on NAV at the last year end, and adjusting for a subsequent placing and dividend distribution, I estimate the stock trades at around a 10% premium to NAV.

It’s not unusual for owners of physical assets that generate resilient cash flows to trade at a premium. Primary Health Properties is another example. In buying Greencoat, I do have to accept the risk of a de-rating of the stock should management fall short in identifying, selecting and executing further investments that deliver satisfactory returns. In such an event, Greencoat’s attractive RPI-linked dividend (forecast 2021 yield of 5.5%) might also be at risk.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Greencoat UK Wind and Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »